In:
American Journal of Medical Genetics Part A, Wiley, Vol. 179, No. 8 ( 2019-08), p. 1591-1597
Kurzfassung:
Despite BMP4 signaling being critical to Rathke's pouch induction and maintenance during early stages of pituitary development, its implication in the etiology of combined pituitary hormone deficiency (CPHD) and other clinical presentations of congenital hypopituitarism has not yet been definitely demonstrated. We report here the first CPHD patient with a de novo pathogenic loss‐of‐function variant in BMP4 . A 6‐year‐old boy, with macrocephaly, myopia/astigmatism, mild psychomotor retardation, anterior pituitary hypoplasia and ectopic posterior pituitary, clinically diagnosed with growth hormone deficiency, and central hypothyroidism, was referred for genetic analysis of CPHD. Targeted NGS analysis with a custom panel ( n = 310 genes) identified a novel heterozygous de novo nonsense variant, NM_001202.5:c.794G 〉 A, p.(Trp265*) in BMP4 , which introduces a premature stop codon in the BMP4 pro‐domain, impairing the transcription of the TGF‐β mature peptide domain. Additional relevant variants in other genes implicated in pituitary development signaling pathways such as SMAD4 and E2F4 (BMP/TGF‐pathway), ALMS1 (NOTCH‐pathway), and TSHZ1 (Prokineticin‐pathway), were also identified. Our results support the implication of the BMP/TGF‐β signaling pathway in the etiology of CPHD and suggest that oligogenic contribution of additional inherited variants may modify the phenotypic expressivity of BMP4 pathogenic variants.
Materialart:
Online-Ressource
ISSN:
1552-4825
,
1552-4833
DOI:
10.1002/ajmg.a.v179.8
DOI:
10.1002/ajmg.a.61201
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2019
ZDB Id:
1493479-6
SSG:
12
